DIFFERENT CLEARANCE OF INTRAVENOUSLY ADMINISTERED OLIVE OIL AND SOYBEAN-OIL EMULSIONS - ROLE OF HEPATIC LIPASE

被引:40
作者
BROUWER, CB
DEBRUIN, TWA
JANSEN, H
ERKELENS, DW
机构
[1] ACAD HOSP UTRECHT,DEPT ENDOCRINOL,UTRECHT,NETHERLANDS
[2] ACAD HOSP UTRECHT,DEPT INTERNAL MED,UTRECHT,NETHERLANDS
[3] UNIV HOSP ROTTERDAM,DEPT MED,ROTTERDAM,NETHERLANDS
关键词
OLEIC ACID; LINOLEIC ACID; FAT EMULSIONS; HEPATIC LIPASE; LIPOPROTEIN LIPASE; APOLIPOPROTEIN-C-II; HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL; PARENTERAL NUTRITION; CHYLOMICRONS;
D O I
10.1093/ajcn/57.4.533
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The elimination of two intravenously administered fat emulsions consisting of either 20% (wt:vol) soybean oil or 17% olive oil plus 3% soybean oil was studied in six normolipidemic young men according to a randomized crossover protocol. Slower elimination was found with the olive oil emulsion. A significantly lower maximal removal capacity (Kl) and fractional catabolic rate (K2) were measured with olive oil emulsion (P < 0.05). Removal of olive oil emulsion was inversely related to hepatic lipase activity (r = -0.85; P < 0.05). Removal of soybean-oil emulsion was related to the initial plasma triglyceride concentration (r = -0.84; P < 0.05) but not to lipolytic activity. In vivo apolipoprotein C-II binding was similar for both emulsions. Therefore, hepatic lipase activity is more important in the elimination of olive oil emulsions than soybean-oil emulsions. The faster elimination of soybean-oil emulsions suggests an additional elimination pathway, such as the reticuloendothelial system.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 48 条
[31]  
MAHLEY RW, 1989, ARTERIOSCLER, V9, P14
[32]  
MAHLEY RW, 1982, MED CLIN N AM, V66, P1277
[33]   MODIFICATION OF LOWRY PROCEDURE TO SIMPLIFY PROTEIN DETERMINATION IN MEMBRANE AND LIPOPROTEIN SAMPLES [J].
MARKWELL, MAK ;
HAAS, SM ;
BIEBER, LL ;
TOLBERT, NE .
ANALYTICAL BIOCHEMISTRY, 1978, 87 (01) :206-210
[34]  
MATTSON FH, 1985, J LIPID RES, V26, P194
[35]  
MENSINK RP, 1989, NEW ENGL J MED, V32, P1436
[36]   BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA [J].
MORGANROTH, J ;
LEVY, RI ;
FREDRICKSON, DS .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) :158-174
[37]  
NESTEL PJ, 1964, J LIPID RES, V5, P46
[38]   EFFECT OF MEDIUM-CHAIN AND LONG-CHAIN TRIGLYCERIDE INFUSION ON LIPOPROTEIN AND HEPATIC LIPASE IN HEALTHY-SUBJECTS [J].
NORDENSTROM, J ;
NEESER, G ;
OLIVECRONA, T ;
WAHREN, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (06) :580-585
[39]   HIGH-DENSITY LIPOPROTEIN2 - RELATIONSHIP OF THE PLASMA-LEVELS OF THIS LIPOPROTEIN SPECIES TO ITS COMPOSITION, TO THE MAGNITUDE OF POSTPRANDIAL LIPEMIA, AND TO THE ACTIVITIES OF LIPOPROTEIN-LIPASE AND HEPATIC LIPASE [J].
PATSCH, JR ;
PRASAD, S ;
GOTTO, AM ;
PATSCH, W .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02) :341-347
[40]  
RIFAI N, 1986, CLIN CHEM, V32, P1969